查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1997396

高通量篩檢市場：按產品類型、技術、板規格、應用和最終用戶分類的全球市場預測，2026-2032年

High-Throughput Screening Market by Product Type, Technology, Plate Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，高通量篩檢市場價值將達到 223.2 億美元，到 2026 年將成長至 232.4 億美元，到 2032 年將達到 334.4 億美元，複合年成長率為 5.94%。

主要市場統計數據
基準年 2025 223.2億美元
預計年份：2026年 232.4億美元
預測年份 2032 334.4億美元
複合年成長率 (%) 5.94%

先進的高通量篩檢時代已經到來，它透過優先考慮檢測準確性、自動化柔軟性和數據完整性來加速藥物發現流程。

高通量篩檢(HTS) 已從一項小眾自動化技術發展成為現代藥物發現和轉化研究的基礎，使研究機構能夠以前所未有的規模快速分析化學空間和生物表現型。如今，實驗室中的 HTS 工作流程整合了先進的檢測系統、自動化液體處理和資料管理平台，從而縮短了從目標識別到先導化合物篩選的時間。隨著各機構尋求加速研發流程並降低失敗率，篩檢能力的評估標準不僅包括通量，還包括柔軟性、檢測準確性以及有助於後續決策的數據品質。

技術、進階分析和服務模式的整合正在重塑篩檢工作流程，以實現更高的準確性和轉化相關性。

高通量定序（HTS）領域正經歷一場變革，其驅動力包括技術的成熟、研發模式的轉變以及對更高資料品質的需求。微流體和晶片實驗室技術的進步顯著降低了試劑消耗，使得以往難以大規模的單細胞檢測和微型化檢測變得更加可行。無標定檢測方法與成像和高內涵分析相結合，能夠產生兼具表現型複雜性和高通量分析能力的混合結果。這些技術進步得益於液體處理精度和微孔板形式的改進，使得在不影響結果重複性的前提下，能夠使用較小的樣本量進行更多類型的檢測。

關稅驅動的採購系統重組和加強供應鏈韌性的措施正在重新定義篩檢作業中的供應商選擇、採購和平台決策。

美國已實施和提案於2025年實施的關稅措施對高通量定序（HTS）生態系統內的籌資策略、供應鏈韌性和成本結構提出了重大考量。對某些類別的設備和進口實驗室耗材徵收的關稅迫使採購團隊重新評估籌資策略，在滿足特定產品性能需求的同時，權衡跨境交易帶來的財務和物流影響。因此，各組織更重視供應商多元化、與本地經銷商建立合作關係，並預留更長的前置作業時間，以降低關稅相關延誤和價格波動帶來的風險。

橫斷面細分分析揭示了產品、技術、版面、應用和最終用戶趨勢如何相互作用並影響採用和價值實現。

細分市場洞察揭示了不同的需求促進因素和技術組合，這些因素指南產品開發和商業化策略。在產品類型細分中，耗材（例如專用實驗室設備、試劑和檢測試劑盒）對於檢測性能至關重要，並且通常決定檢測結果的可重複性；而儀器（包括檢測和液體處理系統）則決定了檢測通量和準確度的上限。涵蓋檢測開發、驗證和篩檢的服務使企業能夠在無需大量資本投入的情況下利用客製化功能，而涵蓋化合物管理和數據分析的軟體產品對於將原始篩檢結果轉化為可操作的候選化合物譜至關重要。這些產品層面的動態造成了相互依​​賴關係，耗材的最佳化、儀器相容性和軟體工作流程的最佳化共同決定了端到端檢測的成功。

美洲、歐洲、中東和非洲以及亞太地區的創新生態系統和監管環境的細微差異，正在推動針對特定區域的採用和夥伴關係策略。

高通量篩檢(HTS) 領域的區域趨勢受到美洲、歐洲、中東和非洲以及亞太地區獨特的創新生態系統、監管環境和商業基礎設施的影響。在美洲，強大的製藥和生物技術公司叢集，以及先進的學術研究網路，共同支持對尖端設備和綜合服務的需求。對轉化研究的投入以及眾多受託研究機構(CRO) 的存在，產生了協同效應，加速了技術應用和合作篩檢計劃的發展。

供應商的整合策略，結合模組化設備、可靠的耗材、檢驗的服務和先進的分析，是其在競爭格局中脫穎而出的關鍵因素。

高通量篩選（HTS）生態系統中的主要企業致力於打造整合的價值提案，將硬體效能、耗材可靠性、服務專長和先進軟體功能融為一體。儀器製造商正在擴展其模組化產品線，以支援高密度篩檢和複雜的表現型分析。他們優先考慮跨平台的互通性和改造升級，從而能夠在不進行設備更換的情況下升級現有工作流程。試劑和實驗室設備供應商認知到，試劑性能直接影響篩選結果的重現性和下游檢驗的成功率，因此正在投資改進配方和品管，以減少批間差異並提高檢測間的一致性。

為了贏得新員工，領導者需要採取切實可行的策略措施來推動互通性、在地支援、嚴格檢驗和靈活的經營模式。

隨著高通量定序 (HTS) 的發展，產業領導者應優先考慮互通性、可復現性和策略夥伴關係夥伴關係，以獲取價值。投資於平台模組化和升級路徑可以減輕採用者的負擔，並維護與現有客戶的關係，使他們能夠在不完全更換系統的情況下擴展功能。同樣，為耗材建立健全的品管標準和透明的檢驗通訊協定，可以贏得研發部門採購負責人的信任，因為他們需要跨站點和研究實驗室的可複現性。透過將產品藍圖與最終用戶的工作流程和相容性要求相匹配，供應商可以降低採用門檻並提高客戶終身價值。

透過嚴格結合專家訪談、技術文獻綜述和交叉檢驗，我們對篩檢技術、工作流程和採購趨勢提供了平衡的見解。

本報告整合了第一手和第二手調查的調查方法，旨在提供關於高通量檢測（HTS）趨勢的平衡且基於實證的觀點。第一手調查包括對設備製造商、耗材供應商、軟體供應商、服務供應商、學術研究人員和採購負責人等領域的意見領袖進行深入訪談，以深入了解HTS的採用促進因素、挑戰和策略重點。這些訪談旨在了解實際決策標準，並檢驗在該領域觀察到的新興趨勢。

綜合解決方案、注重可重複性以及共同採購是將高通量篩檢的進步轉化為一致的藥物發現結果的策略基礎。

高通量篩檢正處於轉折點，技術進步、供應鏈現狀和不斷演進的研發模式相互交織，迫使企業重新調整策略重點。微流體技術、晶片實驗室和無標定檢測技術的成熟，拓展了可大規模運作的檢測範圍。同時，液體處理和微孔板形式的改進，使得工作流程更有效率且可重複。同時，關稅趨勢加劇了採購壓力，區域能力建構的需求也要求企業制定更精細的採購和夥伴關係策略。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：高通量篩檢市場：依產品類型分類

  • 消耗品
    • 實驗室設備
    • 試劑和檢測試劑盒
  • 裝置
    • 檢測系統
    • 液體處理系統
  • 服務
    • 檢測方法開發與驗證
    • 篩檢
  • 軟體
    • 化合物管理
    • 數據分析

第9章：高通量篩檢市場：依技術分類

  • 基於細胞的檢測
    • 螢光成像盤式分析儀儀檢測
    • 基於報告基因的檢測
  • 晶片實驗室技術（LOC）
  • 無標定技術
  • 基於微流體技術的

第10章：以板型分類的高通量篩檢市場

  • 1536孔盤
  • 384孔盤
  • 96孔盤

第11章：高通量篩檢市場：依應用分類

  • 藥物發現
  • 基因組學和蛋白​​質組學
  • 分子篩檢
  • 毒理學和安全性評估

第12章 高通量篩檢市場：依最終使用者分類

  • 學術和研究機構
  • 合約研究機構
  • 醫院/診斷檢查室
  • 製藥和生物技術公司

第13章：高通量篩檢市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：高通量篩檢市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：高通量篩檢市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國高通量篩檢市場

第17章：中國的高通量篩檢市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomat Srl
  • BMG LABTECH GmbH
  • BRAND GMBH+CO KG
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Biolabs, Inc.
  • Danaher Corporation
  • DIANA Biotechnologies, as
  • Eppendorf SE
  • EUROFINS SCIENTIFIC SE
  • Gilson Company, Inc.
  • Hamilton Company
  • HighRes BioSolutions, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Mettler Toledo International, Inc.
  • PerkinElmer, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market was valued at USD 22.32 billion in 2025 and is projected to grow to USD 23.24 billion in 2026, with a CAGR of 5.94%, reaching USD 33.44 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 22.32 billion
Estimated Year [2026] USD 23.24 billion
Forecast Year [2032] USD 33.44 billion
CAGR (%) 5.94%

An evolved high-throughput screening era emphasizing assay fidelity, automation flexibility, and data integrity to accelerate discovery pipelines

High-throughput screening (HTS) has evolved from a niche automation capability into a cornerstone of contemporary drug discovery and translational research, enabling institutions to rapidly interrogate chemical space and biological phenotypes at unprecedented scale. Across laboratories, HTS workflows now integrate advanced detection systems, automated liquid handling, and data management platforms that together compress timelines from target identification to lead selection. As organizations seek to accelerate pipelines and reduce attrition, screening capabilities are increasingly judged not only on throughput but on flexibility, assay fidelity, and the quality of the data that informs downstream decisions.

The convergence of consumables innovation, instrument sophistication, service models, and analytical software has broadened the value proposition of HTS beyond simple large-scale testing. Consumables such as specialized labware and reagent kits are engineered to optimize assay robustness, while detection and liquid handling platforms are being designed to support miniaturized plate formats and complex cell-based readouts. Meanwhile, service providers offering assay development, validation, and end-to-end screening enable organizations without in-house capacity to leverage HTS capabilities rapidly, and software tools for compound management and data analysis are essential to manage the volume and complexity of screening outputs.

Taken together, these dynamics are reshaping priorities for R&D leaders, who now prioritize assay scalability, data integrity, and cross-platform interoperability. This report synthesizes the key technological, regulatory, and commercial drivers that are defining HTS strategy and capability development across academic, clinical, and industrial settings, offering a clear roadmap for decision-makers aiming to translate screening investments into measurable therapeutic and discovery outcomes.

Technological convergence, advanced analytics, and service models are reshaping screening workflows toward higher fidelity and translational relevance

The HTS landscape is undergoing transformative shifts driven by technological maturation, changing R&D models, and the imperative for enhanced data quality. Advances in microfluidics and lab-on-a-chip technologies are enabling dramatic reductions in reagent consumption and facilitating single-cell and miniaturized assays that were previously impractical at scale. Label-free detection modalities are converging with imaging and high-content approaches, creating hybrid readouts that capture phenotypic complexity while preserving throughput. These technological progressions are supported by improvements in liquid handling precision and plate formats, which together allow a broader array of assay types to be executed in smaller volumes without sacrificing reproducibility.

Alongside instrumentation, software and data analytics have shifted from peripheral tools to central pillars of HTS workflows. Compound management systems that integrate with screening platforms now ensure sample traceability and reduce error, while advanced data analysis pipelines-incorporating machine learning and pattern recognition-enhance hit identification and triage. The rise of contract research organizations and service-based screening models has also changed adoption patterns, enabling organizations to access specialized assays and validation services without capital-intensive investments. These shifts encourage portfolio-level experimentation and support adaptive R&D strategies.

Regulatory and quality expectations are simultaneously tightening, prompting suppliers to emphasize assay validation, documentation, and reproducibility. As a result, decision-makers increasingly favor integrated solutions that deliver robustness across consumables, instruments, services, and software. This confluence of developments is redefining what constitutes competitive advantage in HTS, placing a premium on interoperability, translational relevance, and the ability to generate high-confidence data that accelerates downstream development.

Tariff-driven procurement restructuring and supply chain resilience measures are redefining vendor selection, sourcing, and platform decisions in screening operations

United States tariff measures enacted and proposed for 2025 have introduced material considerations for procurement strategies, supply chain resilience, and cost structures within HTS ecosystems. Tariffs on certain categories of instrumentation and imported laboratory consumables have driven procurement teams to reassess sourcing strategies, balancing the need for specific product performance against the financial and logistical implications of cross-border transactions. As a result, organizations have placed greater emphasis on vendor diversification, local distributor relationships, and longer lead-time planning to mitigate exposure to tariff-related delays and price volatility.

In response to tariff pressures, some institutions have increased collaboration with domestic manufacturers and service providers to hedge against supply chain disruptions. This has accelerated interest in modular platforms that can be upgraded or serviced locally, and heightened scrutiny of suppliers' end-to-end sourcing maps. Procurement professionals are also evaluating total cost of ownership more rigorously, factoring in not only initial purchase price but also maintenance, consumable compatibility, and the potential for tariff-driven cost fluctuations.

Moreover, tariffs have spurred innovation in procurement strategies, including pooled purchasing across academic consortia and the use of contract research partnerships to obtain specialized capabilities without transferring capital expense. These adaptations maintain scientific momentum while managing financial impact. Looking ahead, the interplay between trade policy and strategic sourcing will continue to influence vendor selection, platform standardization, and the geography of HTS capability development.

Cross-cutting segmentation analysis reveals how product, technology, plate format, application, and end-user dynamics interact to shape adoption and value realization

Segmentation insights reveal differentiated demand drivers and technology pairings that inform product development and commercialization strategies. Within product type segmentation, consumables such as specialized labware and reagents and assay kits are critical to assay performance and are often the differentiator in reproducibility, while instruments comprising detection systems and liquid handling systems set the ceiling for throughput and precision. Services that encompass assay development and validation as well as screening create pathways for organizations to access bespoke capabilities without heavy capital outlay, and software offerings covering compound management and data analysis are essential to convert raw screening outputs into actionable candidate profiles. These product-level dynamics create interdependencies where consumable optimization, instrument compatibility, and software workflows collectively determine end-to-end assay success.

Technology segmentation highlights the growing prominence of cell-based assays, including fluorometric imaging plate reader assays and reporter-based assays, which are favored for their biological relevance. Parallel advances in lab-on-a-chip and microfluidics based approaches support miniaturized, higher-content assays that reduce reagent use and enable novel experimental designs, while label-free technologies offer complementary kinetic and mechanistic insights. Choices in plate format segmentation-ranging from high-density 1536-well plates to 384-well and 96-well formats-reflect trade-offs between throughput, data quality, and assay complexity, with higher-density plates suitable for large compound libraries and lower-density formats preferred for complex or primary-cell assays.

Application segmentation underscores that drug discovery, genomics and proteomics, molecular screening, and toxicology and safety assessment each impose distinct requirements on throughput, data fidelity, and assay design. End user segmentation shows that academic and research institutes, contract research organizations, hospitals and diagnostic labs, and pharmaceutical and biotechnology companies have diverse priorities tied to budget cycles, regulatory needs, and timelines. Understanding these segmentation layers enables vendors and purchasers to align product roadmaps, service offerings, and support models with the nuanced demands of each user cohort.

Regional innovation ecosystems and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific drive differentiated adoption and partnership strategies

Regional dynamics in the HTS landscape are shaped by distinct innovation ecosystems, regulatory environments, and commercial infrastructures across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, strong pharmaceutical and biotech clusters, coupled with advanced academic research networks, sustain demand for both cutting-edge instrumentation and comprehensive service offerings. Investment in translational research and a large base of contract research organizations create synergies that accelerate technology adoption and collaborative screening projects.

Europe, the Middle East & Africa present a heterogeneous picture where regulatory rigor and strong academic institutions drive high standards for assay validation and data quality. Local manufacturing capabilities in certain European countries support resilient supply chains, and collaborative research initiatives across borders foster technology transfer and standardization efforts. In markets across the Middle East and Africa, concentrated investments in diagnostic capacity and regional centers of excellence are gradually expanding the base of sophisticated screening users.

Asia-Pacific is characterized by rapid capacity expansion, substantial investments in biotech and pharmaceutical manufacturing, and growing internal demand for both instruments and consumables. Domestic suppliers in several Asia-Pacific countries are increasingly competitive on price and are improving on quality, prompting multinational vendors to adapt their regional strategies. Across all regions, cross-border collaboration and knowledge exchange are driving harmonization of best practices, even as local regulatory and procurement nuances continue to influence adoption pathways and partnership structures.

Integrated vendor strategies combining modular instruments, reliable consumables, validated services, and advanced analytics are defining competitive differentiation

Leading companies across the HTS ecosystem are focusing on integrated value propositions that combine hardware performance, consumable reliability, service expertise, and advanced software capabilities. Instrument manufacturers are expanding modular portfolios to support both high-density screening and complex phenotypic assays, prioritizing platform interoperability and retrofitability so that existing workflows can be upgraded without disruptive capital replacement. Suppliers of reagents and labware are investing in formulation improvements and quality control to reduce batch variability and enhance inter-assay consistency, recognizing that reagent performance directly influences hit reproducibility and downstream validation success.

Service providers are differentiating through deep assay development expertise, regulatory-grade validation processes, and flexible engagement models that range from standalone campaigns to long-term partnerships. Software vendors are embedding analytics, visualization, and machine learning into compound management and data analysis solutions, enabling more rapid hit triage and richer biological interpretation. Across the competitive landscape, strategic collaborations and distribution partnerships are common as companies seek to assemble comprehensive solutions that address enterprise pain points related to throughput, data integrity, and cross-platform compatibility.

Companies that demonstrate responsiveness to procurement pressures-such as local support infrastructure and total cost of ownership transparency-tend to gain traction with institutional buyers. Those that invest in partnerships with academic centers and CROs to validate translational relevance of their platforms build credibility among translational researchers and commercial developers. Overall, the most successful firms balance technological leadership with service excellence and pragmatic deployment models to maximize adoption across diverse end users.

Practical strategic moves for leaders to advance interoperability, regional support, validation rigor, and flexible commercial models to win adoption

Industry leaders should prioritize interoperability, reproducibility, and strategic partnerships to capture value as HTS evolves. Investments in platform modularity and upgrade pathways reduce friction for adopters and protect installed-base relationships, enabling customers to expand capabilities without wholesale replacement. Similarly, establishing robust quality control standards for consumables and transparent validation protocols builds trust with R&D buyers who demand reproducibility across sites and studies. By aligning product roadmaps with end-user workflows and compatibility requirements, suppliers can lower barriers to adoption and increase lifetime customer value.

Building regional service footprints and trusted distributor networks mitigates procurement risks and counters tariff-induced supply chain pressures. Collaborations with academic centers and CROs can accelerate real-world validation, broaden addressable use cases, and create referral pathways into long-term commercial relationships. On the software side, embedding analytics and machine learning into compound management and data analysis reduces time-to-insight and enhances decision-making across hit selection and lead optimization. Firms should also offer flexible commercial models, including service subscriptions and outcome-aligned contracts, to meet the evolving budgetary preferences of academic, clinical, and industrial buyers.

Finally, leaders should adopt transparent total cost of ownership messaging and provide robust post-sale support, training, and validation services. These measures not only improve customer satisfaction but also protect revenue streams by reinforcing the value of integrated hardware, consumables, services, and software in delivering high-confidence screening outcomes.

A rigorous blend of expert interviews, technical literature review, and cross-validation delivers balanced insights into screening technologies, workflows, and sourcing dynamics

This report synthesizes primary and secondary research methodologies to ensure a balanced and evidence-based perspective on HTS dynamics. Primary research comprised in-depth interviews with thought leaders across instrument manufacturing, consumables supply, software vendors, service providers, academic researchers, and procurement professionals, providing qualitative insights into adoption drivers, pain points, and strategic priorities. These conversations were conducted to capture real-world decision criteria and to validate emerging trends observed in the field.

Secondary research involved systematic review of peer-reviewed literature, regulatory guidance, technical specifications, product white papers, and conference proceedings to contextualize technological developments and validate performance claims. Comparative analysis of platform capabilities, assay types, and end-user requirements informed segmentation logic and allowed the synthesis of cross-cutting themes. Triangulation of primary and secondary inputs ensured robust interpretation of supply chain implications, tariff impacts, and regional adoption patterns.

Throughout the research process, special attention was given to reproducibility metrics, assay validation practices, and data management approaches to reflect the factors that most influence practical adoption. Limitations and uncertainties were acknowledged where proprietary performance data were unavailable, and recommendations are framed to be actionable within the bounds of accessible evidence.

Integrated solutions, reproducibility focus, and collaborative sourcing form the strategic foundation for turning high-throughput screening advances into consistent discovery outcomes

High-throughput screening stands at an inflection point where technological advances, supply chain realities, and evolving R&D models intersect to reshape strategic priorities. The maturation of microfluidics, lab-on-a-chip, and label-free detection is expanding the repertoire of assays that can be executed at scale, while improvements in liquid handling and plate formats enable more efficient and reproducible workflows. At the same time, procurement pressures-exacerbated by tariff dynamics-and regional capability building necessitate more sophisticated sourcing and partnership strategies.

For stakeholders across academic, clinical, and industrial settings, the path forward emphasizes integrated solutions that pair robust consumables and adaptable instruments with validated services and advanced analytics. Such approaches reduce operational risk, increase the translational relevance of screening outputs, and accelerate decision-making in lead discovery and safety assessment. Strategic collaboration, regional support infrastructure, and transparent validation practices will be critical in converting technological potential into consistent scientific outcomes.

In summary, organizations that prioritize interoperability, data quality, and flexible engagement models will be best positioned to harness the current wave of HTS innovation and translate screening investments into sustainable discovery performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. High-Throughput Screening Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Labware
    • 8.1.2. Reagents & Assay Kits
  • 8.2. Instruments
    • 8.2.1. Detection Systems
    • 8.2.2. Liquid Handling Systems
  • 8.3. Services
    • 8.3.1. Assay Development & Validation
    • 8.3.2. Screening
  • 8.4. Software
    • 8.4.1. Compound Management
    • 8.4.2. Data Analysis

9. High-Throughput Screening Market, by Technology

  • 9.1. Cell-Based Assays
    • 9.1.1. Fluorometric Imaging Plate Reader Assays
    • 9.1.2. Reporter based Assays
  • 9.2. Lab-on-a-chip Technology (LOC)
  • 9.3. Label-free Technology
  • 9.4. Microfluidics Based

10. High-Throughput Screening Market, by Plate Format

  • 10.1. 1536-well plate
  • 10.2. 384-well plate
  • 10.3. 96-well plate

11. High-Throughput Screening Market, by Application

  • 11.1. Drug Discovery
  • 11.2. Genomics & Proteomics
  • 11.3. Molecular Screening
  • 11.4. Toxicology & Safety Assessment

12. High-Throughput Screening Market, by End User

  • 12.1. Academic & Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Diagnostic Labs
  • 12.4. Pharmaceutical & Biotechnology Companies

13. High-Throughput Screening Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. High-Throughput Screening Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. High-Throughput Screening Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States High-Throughput Screening Market

17. China High-Throughput Screening Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Aurora Biomed, Inc.
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. Biomat S.r.l
  • 18.9. BMG LABTECH GmbH
  • 18.10. BRAND GMBH + CO KG
  • 18.11. Charles River Laboratories International, Inc.
  • 18.12. Corning Incorporated
  • 18.13. Creative Biolabs, Inc.
  • 18.14. Danaher Corporation
  • 18.15. DIANA Biotechnologies, a.s
  • 18.16. Eppendorf SE
  • 18.17. EUROFINS SCIENTIFIC SE
  • 18.18. Gilson Company, Inc.
  • 18.19. Hamilton Company
  • 18.20. HighRes BioSolutions, Inc.
  • 18.21. Lonza Group AG
  • 18.22. Merck KGaA
  • 18.23. Mettler Toledo International, Inc.
  • 18.24. PerkinElmer, Inc.
  • 18.25. Revvity, Inc.
  • 18.26. Sartorius AG
  • 18.27. Tecan Trading AG
  • 18.28. Thermo Fisher Scientific Inc.
  • 18.29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REAGENTS & ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LIQUID HANDLING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ASSAY DEVELOPMENT & VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COMPOUND MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DATA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY FLUOROMETRIC IMAGING PLATE READER ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REPORTER BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LAB-ON-A-CHIP TECHNOLOGY (LOC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY LABEL-FREE TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MICROFLUIDICS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 1536-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 384-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY 96-WELL PLATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GENOMICS & PROTEOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY MOLECULAR SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TOXICOLOGY & SAFETY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 209. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 236. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 242. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 247. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 248. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 253. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)